actinic keratosis therapy (Issar)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameactinic keratosis therapy (Issar)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsKeratosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIssar Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIssar Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsKeratosis

Other Information

ATC CodeN/A
Related LinksN/A